Real-Time PCR Cycle Threshold (Ct) values have become a widely debated metric in the management of SARS-CoV-2 infection; however, their interpretive utility remains controversial. While Ct values may help augment the interpretation of a positive test, variability in clinical presentation and sample-related challenges necessitate that Ct values be framed within the context of the clinical presentation.
Join this webinar to hear Drs. Goldstein and Gendlina review this timely topic as well as scenarios, opportunities and limitations in the clinical utility of Ct values.
Dr. Yitz Goldstein, MD, FASCP, Director, Molecular Pathology Laboratory, Director, Virology Laboratory, Montefiore Medical Center
Dr. Yitz Goldstein attended the Albert Einstein College of Medicine and completed his residency in Anatomic and Clinical Pathology at Montefiore Medical Center. He went on to complete a molecular genetic pathology fellowship at the Mount Sinai School of Medicine. Dr. Goldstein is currently Assistant Professor of Pathology at the Albert Einstein College of Medicine and Director of Molecular Infectious disease testing and Director of the Molecular pathology laboratory at Montefiore Medical Center.Message Presenter
Dr. Inessa Gendlina, MD, PhD, Assistant Professor, Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center
Dr. Inessa Gendlina is a Board-certified Infectious Diseases physician and an assistant professor of Medicine at the Montefiore Albert Einstein College of Medicine. In addition to her medical degree, she holds a PhD in Microbiology. Since the pandemic, she serves as the content expert in Infectious Diseases and Infection Control/Epidemiology at the Montefiore Medical Center.Message Presenter
Who Should Attend?
This webinar will benefit those with the following job titles/job areas:
- Laboratory Managers
- Laboratory Directors
- Infectious Disease Physicians
- Internal Medicine Physicians
- Hospital Physicians
- Antimicrobial stewardship committees
- Infection control committees
What You Will Learn
Join this webinar to understand how Ct values obtained from real-time PCR instrumentation have been implemented into clinical workflows and utilized in a diagnostic setting during the COVID-19 pandemic.
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Further information can be found at http://www.qiagen.com.